FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization

Qiu, A., Miller, A., Zotti, F. D., Santhanakrishnan, M., Hendrickson, J. E., Tredicine, M., Stowell, S. R., Luckey, C. J., Zimring, J. C., & Hudson, K. E. (2022). FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.972723
Authors:
Annie Qiu
Anabel Miller
Flavia Dei Zotti
Manjula Santhanakrishnan
Jeanne E. Hendrickson
Maria Tredicine
Sean R. Stowell
Chance John Luckey
James C. Zimring
Krystalyn E. Hudson
Affiliated Authors:
Annie Qiu
Anabel Miller
Flavia Dei Zotti
Krystalyn E. Hudson
Columbia Affiliation:
Subjects:
Anemia, Hemolytic, Autoimmune (MeSH)
Antigen-Antibody Complex (MeSH)
Diseases Related to Blood Group Variants (OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
Glycosylation in Health and Disease (OpenAlex Topic)
Author Keywords:
fc receptor
antibody
red blood cell
alloantibody
antibody mediated enhancement
elink
Publication Type:
Article
Unique ID:
10.3389/fimmu.2022.972723
PMID:
36189253
DOI:
10.3389/fimmu.2022.972723
Journal:
Frontiers in Immunology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: